Klea Holding (ALKLH) | Financial Analysis & Statements
Klea Holding Inc. | Small-cap | Healthcare
Klea Holding Inc. | Small-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
17.3M
Gross Profit
8.3M
47.82%
Operating Income
1.9M
11.28%
Net Income
1.4M
8.14%
Balance Sheet Metrics
Total Assets
37.8M
Total Liabilities
10.0M
Shareholders Equity
27.8M
Debt to Equity
0.36
Cash Flow Metrics
Operating Cash Flow
769.0K
Free Cash Flow
166.0K
Revenue & Profitability Trend
Klea Holding Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 17.3M | 13.7M | 14.4M | 7.2M | 19.0M |
| Cost of Goods Sold | 9.0M | 7.4M | 11.2M | 7.9M | 22.7M |
| Gross Profit | 8.3M | 6.3M | 3.2M | -715.0K | -3.8M |
| Operating Expenses | 0 | 23.0K | 801.0K | 832.0K | -786.0K |
| Operating Income | 1.9M | 952.0K | -3.9M | -3.7M | -6.6M |
| Pre-tax Income | 1.5M | 1.5M | -5.1M | -4.2M | -5.2M |
| Income Tax | 267.0K | -37.0K | 113.0K | 142.0K | -164.0K |
| Net Income | 1.4M | 902.0K | -5.3M | -4.5M | -5.2M |
| EPS (Diluted) | - | €0.00 | -€0.02 | -€0.03 | -€0.20 |
Income Statement Trend
Klea Holding Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 7.1M | 5.3M | 7.0M | 16.0M | 5.1M |
| Non-Current Assets | 30.7M | 31.3M | 29.1M | 28.1M | 832.0K |
| Total Assets | 37.8M | 36.6M | 36.1M | 44.1M | 5.9M |
| Liabilities | |||||
| Current Liabilities | 3.5M | 3.4M | 5.5M | 24.2M | 8.8M |
| Non-Current Liabilities | 6.5M | 8.5M | 6.3M | 5.8M | 1.5M |
| Total Liabilities | 10.0M | 11.8M | 11.8M | 30.0M | 10.3M |
| Equity | |||||
| Total Shareholders Equity | 27.8M | 24.7M | 24.3M | 14.1M | -4.4M |
Balance Sheet Composition
Klea Holding Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.2M | 902.0K | -5.3M | -4.5M | -5.2M |
| Operating Cash Flow | 769.0K | -1.3M | -5.3M | -4.5M | -5.2M |
| Investing Activities | |||||
| Capital Expenditures | -626.0K | -1.8M | -5.5M | -171.0K | 3.1M |
| Investing Cash Flow | -626.0K | -1.6M | -17.5M | -15.0M | 3.1M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -199.0K | 1.0M | 14.8M | 27.2M | 0 |
| Free Cash Flow | 166.0K | -1.5M | -7.3M | -6.7M | -11.1M |
Cash Flow Trend
Klea Holding Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
17.87
Price to Book
1.92
Price to Sales
3.12
Profitability Ratios
Profit Margin
8.14%
Operating Margin
14.55%
Return on Equity
5.35%
Return on Assets
3.27%
Financial Health
Current Ratio
1.41
Debt to Equity
21.13
Beta
-1.12
Per Share Data
EPS (TTM)
€0.00
Book Value per Share
€0.09
Revenue per Share
€0.06
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| alklh | 53.9M | 17.87 | 1.92 | 5.35% | 8.14% | 21.13 |
| Lumibird S.A | 353.3M | 61.73 | 1.78 | 2.91% | 2.71% | 81.34 |
| Eurofins Cerep SAS | 103.9M | 14.33 | - | 10.49% | 17.67% | 0.46 |
| Predilife S.A | 13.9M | - | - | -4,653.75% | 97.76% | -1.16 |
| bioMérieux S.A | 14.2B | 32.96 | 3.37 | 10.68% | 10.86% | 11.65 |
| Eurofins Scientific | 10.6B | 28.48 | 2.56 | 7.71% | 5.85% | 67.05 |
Financial data is updated regularly. All figures are in the company's reporting currency.